Literature DB >> 8789602

The role of various calcium and potassium channels in the regulation of somatodendritic serotonin release.

E Bagdy1, L G Harsing.   

Abstract

We prepared slices from midbrain containing the raphe nuclei and from hippocampus of rats. The brain slices were loaded with [3H]serotonin and superfused in order to measure the release of radioactivity at rest and in response to electrical stimulation. No difference was observed in the resting and stimulated fractional release of tritium in the somatodendritic and axon terminal parts of serotonergic neurons. The selective 5-HT1A receptor agonist 8-OH-DPAT decreased the electrically induced tritium efflux from raphe nuclei slices preloaded with [3H]serotonin, and this inhibition was reversed by the 5-HT1A receptor antagonist (+)WAY-100135. The 5-HT1B receptor agonist CGS-12066B but not 8-OH-DPAT, inhibited the stimulation-evoked tritium efflux from hippocampal slices after labeling with [3H]serotonin. The electrical stimulation-evoked tritium efflux in raphe nuclei slices incubated with [3H]serotonin was completely external Ca(2+)-dependent, and omega-conotoxin GVIA and Cd2+, but not diltiazem, inhibited the tritium overflow. In raphe nuclei slices 4-aminopyridine enhanced the electrical stimulation-induced tritium release in a concentration-dependent manner. The inhibition of tritium efflux by 8-OH-DPAT was abolished with 4-aminopyridine. Glibenclamide or tolbutamide proved to be ineffective. These data indicate that (1) different 5-HT receptor subtypes (5-HT1A and 5-HT1B) regulate dendritic and axon terminal 5-HT release; (2) serotonin release from the dendrites may be regulated by the voltage-sensitive N-type Ca2+ channels; (3) the 5-HT1A receptor-mediated inhibition of serotonin release may be due to opening of voltage-sensitive K+ channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789602     DOI: 10.1007/bf00970588

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

Review 1.  Exocytotic Ca2+ channels in mammalian central neurons.

Authors:  K Dunlap; J I Luebke; T J Turner
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

2.  Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons.

Authors:  R B Innis; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1987-11-10       Impact factor: 4.432

3.  Alpha-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating.

Authors:  D Lipscombe; S Kongsamut; R W Tsien
Journal:  Nature       Date:  1989-08-24       Impact factor: 49.962

4.  5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

5.  Acute or chronic changes of noradrenergic transmission do not affect the alpha-adrenoceptor-mediated inhibition of 3H-serotonin release in the cerebral cortex.

Authors:  E Schlicker; M Göthert; R Clausing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

6.  Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol.

Authors:  D N Middlemiss
Journal:  Eur J Pharmacol       Date:  1984-06-01       Impact factor: 4.432

7.  Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons.

Authors:  R B Innis; E J Nestler; G K Aghajanian
Journal:  Brain Res       Date:  1988-08-30       Impact factor: 3.252

8.  Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.

Authors:  P Blier; A Lista; C De Montigny
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

9.  Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist.

Authors:  R F Neale; S L Fallon; W C Boyar; J W Wasley; L L Martin; G A Stone; B S Glaeser; C M Sinton; M Williams
Journal:  Eur J Pharmacol       Date:  1987-04-07       Impact factor: 4.432

10.  Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.

Authors:  S Gaur; R Newcomb; B Rivnay; J R Bell; D Yamashiro; J Ramachandran; G P Miljanich
Journal:  Neuropharmacology       Date:  1994-10       Impact factor: 5.250

View more
  5 in total

1.  Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.

Authors:  Szilvia Vas; Zita Kátai; Diána Kostyalik; Dorottya Pap; Eszter Molnár; Péter Petschner; Lajos Kalmár; György Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-06-24       Impact factor: 3.575

2.  Reciprocal innervation between serotonergic and GABAergic neurons in raphe nuclei of the rat.

Authors:  E Bagdy; I Kiraly; L G Harsing
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

3.  A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.

Authors:  Laszlo G Harsing; Ibolya Prauda; Jozsef Barkoczy; Peter Matyus; Zsolt Juranyi
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

4.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

5.  Activation of the glucocorticoid receptor rapidly triggers calcium-dependent serotonin release in vitro.

Authors:  Nicolas Paul; Justine Raymond; Sara Lumbreras; Dusan Bartsch; Tillmann Weber; Thorsten Lau
Journal:  CNS Neurosci Ther       Date:  2021-03-14       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.